‘Much-needed, timely support’: Industry experts welcome Modi govt’s financial aid to healthcare sector in India

‘Much-needed, timely support’: Industry experts welcome Modi govt’s financial aid to healthcare sector in India

She also announced an outlay of Rs 23,200 crore that needs to be immediately made available to the Union Health Ministry Healthcare sector in India: Finance Minister Nirmala Sitharaman took cognisance of the economic devastation that the second wave of the coronavirus pandemic caused and accordingly, on Monday announced a slew of measures to boost … Read more

Covid-19 third wave not likely to come soon, notion of kids being impacted unfounded, says Dr Mathew Varghese

Covid-19 third wave not likely to come soon, notion of kids being impacted unfounded, says Dr Mathew Varghese

Dr Varghese also said that in the second wave, most symptoms were getting fast forwarded. Coronavirus third wave: The second wave of the coronavirus pandemic wreaked havoc in India, taking the number of daily cases and deaths to an unprecedented high during April-end and May. During this, the country also saw an oxygen crisis and … Read more

Covid-19 third wave: As states begin unlocking, ‘next three months crucial for India’, says AIIMS chief

Covid-19 third wave: As states begin unlocking, ‘next three months crucial for India’, says AIIMS chief

A very strong system of surveillance is required in the country to be able to identify the hotspots. Coronavirus unlock in India: As the country deals with a receding second wave of coronavirus, many cities and states across India are opening up despite the Delta variant of SARS-CoV-2 still being present in the community. Now, … Read more

Coronavirus vaccine: Where does India stand in carrying out national immunisation drive? Virologist explains

Coronavirus vaccine: Where does India stand in carrying out national immunisation drive? Virologist explains

Both Moderna’s and Pfizer-BioNTech’s vaccine candidates have reported an efficacy rate of 95%. Coronavirus vaccine in India: Amid rising global coronavirus caseload and deaths, the news about successful vaccine trials has come as a relief. Both Moderna’s and Pfizer-BioNTech’s vaccine candidates have reported an efficacy rate of 95% in Phase 3 trials conducted at a … Read more